Skip to content

Dr. Lemahieu Nefrologie

Active Private limited company (pre-2019)founded 2007active for 19 yearsBergenlaan 20, 3360 BierbeekKBO/BCE: BE 0893.501.840 #6 company by equity in Bierbeek, Health and social work sector

Lifetime

18 annual accounts with figures on one time axis
peak of €423,618 in 2025
€423,618▲ 10.9%
peak of €289,515 in 2025
€289,515▲ 6.0%
peak of €2.0m in 2024
€1.2m▼ 40.3%
€28,552▲ 392%
Board1 name since 2021
1 director
Documentsfilings and deeds
26-08-202626 days late
2025micro format
Dividend €1.1mEquity from €2.0m to €1.2mDebts from €5,808 to €28,552Cash from €1.1m to €177,935

Key points

from the 2025 annual accounts

Equity

€1.2m ▼ 40.3%
2.02024+0.3Profit-1.1Dividend1.22025

Dr. Lemahieu Nefrologie paid out €1.1m in dividends. That is 382% of the 2025 profit.

Filings

18 annual accounts since 2008
AprilJune31 JulyOctober2010201520202025

Seven of the last ten came late. The 2019 accounts came in latest, 70 days after the end of the period.

Position in the sector

97.7%

Higher solvency than 95% of companies in human health. Sector median 63.0% · 21,347 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,816 companies had the same profile as Dr. Lemahieu Nefrologie has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,816 companies, not a prediction for Dr. Lemahieu Nefrologie. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0893501840
Incorporation published on 27-11-2007 · Gazette deed
All 33 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Lemahieu Nefrologie Bierbeek €1.2m €423,618 97.7% -
Dr Katrien Lagey Kapelle-op-den-Bos €1.3m €454,119 58.6% -
DR.GOETHALS MIRANDA-OFTALMOGIE Beersel €1.4m €418,500 81.8% 0
DR. VEERLE PROVOOST, RADIOLOGIE Leuven €1.4m €425,796 77.6% 0.3
NEURO REVA Beveren-Kruibeke-Zwijndrecht €1.2m €422,984 99.0% -
DOKTER VAN RAEBROECKX ANTOON Puurs-Sint-Amands €1.3m €425,068 84.4% -
Dr. Marijke Aerts Antwerp €1.2m €422,978 38.8% -

These companies have the same main activity as Dr. Lemahieu Nefrologie: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.2m and €1.4m, founded between 2005 and 2009.

Official details

Source: KBO
Status
Active since 09-11-2007Normal situation
Activity
Specialist medical practiceNACE 86220and 1 other
Financial year end
31 December
Peppol
Reachable since 10-12-2025
Company details

Annual accounts 2025

≈ €640,000estimated
€1.2m▼ 39.1%
Filing
Filed on 26-08-2026
Financials

Insights on Dr. Lemahieu Nefrologie

Dr. Lemahieu Nefrologie files the micro format. That format states no turnover. The gross margin rose from €130,830 in 2008 to €423,618 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Lemahieu Nefrologie

What is the company number of Dr. Lemahieu Nefrologie?
The company number of Dr. Lemahieu Nefrologie is 0893.501.840. The VAT number is the same number with BE in front: BE 0893.501.840.
Where is Dr. Lemahieu Nefrologie based?
The registered office is at Bergenlaan 20, 3360 Bierbeek.Company details
What does Dr. Lemahieu Nefrologie do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Lemahieu Nefrologie?
Dr. Lemahieu Nefrologie is a private limited company (pre-2019) (BVBA).
When was Dr. Lemahieu Nefrologie founded?
Dr. Lemahieu Nefrologie was founded on 09-11-2007.
Is Dr. Lemahieu Nefrologie still active?
Yes, Dr. Lemahieu Nefrologie is an active enterprise in the KBO register.
What is the turnover of Dr. Lemahieu Nefrologie?
The turnover in financial year 2025 is ≈ €640,000. This figure is estimated from the gross margin of €423,618 and 31 comparable companies (NACE 86220). It probably lies between €560,000 and €890,000.Financials
Is Dr. Lemahieu Nefrologie profitable?
In financial year 2025, Dr. Lemahieu Nefrologie made a profit of €289,515.
Where can I find the annual accounts of Dr. Lemahieu Nefrologie?
Dr. Lemahieu Nefrologie filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Lemahieu Nefrologie due?
Dr. Lemahieu Nefrologie must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.